Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is a combination of cantharides (the dried bodies or extract of blister beetles, containing the active compound cantharidin) and white mustard seed (Brassica alba). Cantharidin is a terpenoid vesicant historically used as a topical agent for wart removal and molluscum contagiosum, but it is highly toxic if ingested. It acts as a potent blistering agent by causing acantholysis in the skin. White mustard seed has been used in traditional medicine for chest congestion, joint pain, sore throat, and other conditions; its mechanism involves mild antibacterial activity due to certain phytochemicals. There is no strong scientific evidence supporting the efficacy of this combination for any specific indication. Both components are known irritants when applied topically or ingested in large amounts[3][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on cantharides + white mustard seed.